Merck recently settled a patent dispute with Bristol-Myers Squibb and Ono Pharmaceutical over its highly effective cancer treatment drug Keytruda. As part of the settlement Merck will pay $625m as well as royalties to Bristol-Myers Squibb and Ono Pharmaceutical. The… Continue Reading →
Gilead Sciences was recently ordered to pay $2.54 billion to Merck to resolve a long-running patent dispute concerning its blockbuster patent sellers Sovaldi (earning Gilead $19 billion) and Harvoni (earning Gilead $23 billion) for hepatitis C treatment. The patent dispute… Continue Reading →
© 2024 Dawn Ellmore Employment's Blog — Powered by WordPress
Theme by Anders Noren — Up ↑